Skip to main content
SpringerLink
Log in

Post-Stroke Cognitive Impairments and the Potential for Treatment with Cellex

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Objective. To assess the neuropsychological characteristics of post-stroke cognitive impairments (PSCI) in the acute period of ischemic stroke (IS) and to evaluate the efficacy of Cellex. Materials and methods. Complex neuropsychological testing was performed in 288 patients in the acute period of IS. Cellex was used in addition to basal treatment in 30 patients at a dose of 0.1 mg (1 ml) s.c. for 10 days, with treatment being initiated in the hyperacute period. Results and discussion. Multifunctional PSCI was detected in 87% of the patients in the acute period of IS. Most patients showed impairments to attention, regulatory functions, speech, and memory. More than a third of patients showed multifunctional non-amnestic cognitive impairments. Monofunctional nonamnestic PSCI was encountered in 5.5% of cases. Isolated memory deficit was found in 2% of patients. Most elderly patients displayed PSCI, mostly the mixed variant. Isolated decreases in the rate or regulation of cognitive activity dominated among young and middle-aged patients, with one in four patients showing mixed cognitive impairments. A tendency to greater age was seen in patients with mixed-type PSCI. Analysis of the efficacy of Cellex in the acute period of IS showed that use was linked with improvements in cognitive status and the state of neurodynamic, regulatory, and visuospatial functions. The neurotrophic agent Cellex was effective in correcting PSCI in the acute period of IS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C. Gutierrez Perez, M. Savborg, U. Pahlman, et al., “High frequency of cognitive dysfunction before stroke among older people,” Int. J. Geriatr. Psychiatry, 26, 622–629 (2011), doi: https://doi.org/10.1002/gps.2573.

    Article  CAS  PubMed  Google Scholar 

  2. J. C. L. Looi and P. Sachdev, “Differentiation of vascular dementia from AD on neuropsychological tests,” Neurology, 53, 670–678 (1999), doi: https://doi.org/10.1212/wnl.53.4.670.

    Article  CAS  PubMed  Google Scholar 

  3. P. S. Sachdev, X. Chen, H. Brodaty, et al., “The determinants and longitudinal course of post-stroke mild cognitive impairment,” J. Int. Neuropsychol. Soc., 15, 915–923 (2009), doi: https://doi.org/10.1017/S13556 17709990579.

  4. P. B. Gorelick, A. Scuteri, S. E. Black, et al., “Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, 42, No. 9, 2672–2713 (2011), doi: https://doi.org/10.1161/STR.0b013e3182299496.

    Article  PubMed  PubMed Central  Google Scholar 

  5. R. C. Petersen, “Mild cognitive impairment as a diagnostic entity,” J. Int. Med., 256, No. 3, 183–194 (2004), doi: https://doi.org/10.1111/j.1365-2796. 2004.01388.x.

  6. O. S. Levin, Diagnosis and Treatment of Dementia in Clinical Practice: Monograph, MEDpress-Inform, Moscow (2010), 1st ed.

  7. S. J. Cho, K. H. Yu, M. S. Oh, et al., “Post-stroke memory impairment among patients with vascular mild cognitive impairment,” BMC Neurol., 14, 244 (2014), doi: https://doi.org/10.1186/s12883-014-0244-6.

    Article  PubMed  PubMed Central  Google Scholar 

  8. L. Snaphaan and F.-E. de Leeuw, “Post-stroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates,” Stroke, 38, 198–203 (2007), doi: https://doi.org/10.1161/01.str.0000251842.34322.8f.

    Article  PubMed  Google Scholar 

  9. A. A. Kulesh and V. V. Shestakov, “Heterogeneity in cognitive impairments in the acute period of first ischemic hemisphere stroke,” Zh. Nevrol. Psikhiat. (Stroke), 8, No. 8, Iss. 2, 31–34 (2012).

  10. A. A. Kulesh, T. V. Lapaeva, and V. V. Shestakov, “Chronobiological characteristics of stroke and post-stroke cognitive impairments,” Zh. Nevrol. Psikhiat., 114, No. 11, 31–34 (2014).

    Google Scholar 

  11. W. Liu, A. Wong, L. Au, et al., “Influence of amyloid-β on cognitive decline after stroke/transient ischemic attack: three-year longitudinal study,” Stroke, 46, No. 11, 3074–3080 (2015), doi: https://doi.org/10.1161/STROKEAHA.115.010449.

    Article  CAS  PubMed  Google Scholar 

  12. Y. K. Jang, H. Kwon, Y. J. Kim, et al., “Early- vs late-onset subcortical vascular cognitive impairment,” Neurology, 86, No. 6,527–534 (2016), doi: https://doi.org/10.1212/WNL.0000000000002357.

    Article  CAS  PubMed  Google Scholar 

  13. C. R. Jack, Jr, T. M. Therneau, H. J. Wiste, et al., “Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study,” Lancet Neurol., 15, No. 1, 56–64 (2016), doi: https://doi.org/10.1016/S1474-4422(15)00323-3.

    Article  CAS  PubMed  Google Scholar 

  14. A. V. Kovalenko, and M. N. Safronova, “Effects of Cellex on the recovery of cognitive and speech impairments in the acute period of stroke,” Zh. Nevrol. Psikhiat., 115, No. 1, 40–44 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vagner Perm State Medical University, Perm, Russia

    A. A. Kulesh & V. V. Shestakov

Authors
  1. A. A. Kulesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. V. Shestakov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. A. Kulesh.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 116, No. 5, pp. 38–42, May, 2016.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kulesh, A.A., Shestakov, V.V. Post-Stroke Cognitive Impairments and the Potential for Treatment with Cellex. Neurosci Behav Physi 47, 908–912 (2017). https://doi.org/10.1007/s11055-017-0490-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-017-0490-3

Keywords

Search

Navigation